Literature DB >> 26756117

Bone Structure and Predictors of Fracture in Type 1 and Type 2 Diabetes.

Jakob Starup-Linde1, Simon Lykkeboe1, Søren Gregersen1, Ellen-Magrethe Hauge1, Bente Lomholt Langdahl1, Aase Handberg1, Peter Vestergaard1.   

Abstract

CONTEXT: Type 1 and type 2 diabetes mellitus are associated with an increased risk of fracture.
OBJECTIVE: The objective of the study was to compare the bone structure and density between type 1 and type 2 diabetes patients and to investigate fracture associations.
DESIGN: This was a cross-sectional study. SETTING AND PATIENTS: Physician-diagnosed type 1 and type 2 diabetes patients were included from the outpatient clinics at two university hospitals participated in the study. MAIN OUTCOME MEASURES: Bone density and structure were assessed by dual-energy x-ray absorptiometry and high-resolution peripheral quantitative computed tomography. Blood samples were collected for bone turnover markers. Prevalent vertebral fractures were assessed by vertebral fracture assessment and x-ray, and incident fractures were collected from The Danish National Hospital Discharge Register.
RESULTS: Bone mineral density (BMD) was higher in type 2 than type 1 diabetes patients at the hip, femur, and spine; however, only the hip differed in multivariate-adjusted models. Bone tissue stiffness at the tibia was increased in type 2 diabetes patients also in adjusted models. Sclerostin levels were inversely associated with fracture in type 1 diabetes patients. The patients with the highest tertile of sclerostin had an 81% decreased risk of a fracture compared with the lowest tertile.
CONCLUSIONS: Type 1 and type 2 diabetes patients differ in BMD of the hip and tissue stiffness at the tibia. Sclerostin may be a marker independent of BMD to predict fractures in type 1 diabetes patients and thus potentially of clinical importance. Studies with longer follow-up are needed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26756117     DOI: 10.1210/jc.2015-3882

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

1.  High fat diet attenuates hyperglycemia, body composition changes, and bone loss in male streptozotocin-induced type 1 diabetic mice.

Authors:  Adriana Lelis Carvalho; Victoria E DeMambro; Anyonya R Guntur; Phuong Le; Kenichi Nagano; Roland Baron; Francisco José Albuquerque de Paula; Katherine J Motyl
Journal:  J Cell Physiol       Date:  2017-08-04       Impact factor: 6.384

Review 2.  Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

Authors:  Hillary A Keenan; Ernesto Maddaloni
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 3.  Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.

Authors:  Evangelia Kalaitzoglou; Iuliana Popescu; R Clay Bunn; John L Fowlkes; Kathryn M Thrailkill
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 4.  Epidemiology of Skeletal Health in Type 1 Diabetes.

Authors:  David R Weber; George Schwartz
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 5.  The New Possibilities from "Big Data" to Overlooked Associations Between Diabetes, Biochemical Parameters, Glucose Control, and Osteoporosis.

Authors:  Christian Kruse
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

Review 6.  Assessment of bone quality in patients with diabetes mellitus.

Authors:  N Jiang; W Xia
Journal:  Osteoporos Int       Date:  2018-05-07       Impact factor: 4.507

Review 7.  Energy Metabolism of Bone.

Authors:  Katherine J Motyl; Anyonya R Guntur; Adriana Lelis Carvalho; Clifford J Rosen
Journal:  Toxicol Pathol       Date:  2017-11-02       Impact factor: 1.902

8.  Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus.

Authors:  S C DeShields; T D Cunningham
Journal:  J Endocrinol Invest       Date:  2018-01-20       Impact factor: 4.256

9.  The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.

Authors:  J Aleksova; S Kurniawan; G J Elder
Journal:  Osteoporos Int       Date:  2018-03-19       Impact factor: 4.507

10.  Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes.

Authors:  Jessica R Furst; Leonardo C Bandeira; Wen-Wei Fan; Sanchita Agarwal; Kyle K Nishiyama; Donald J McMahon; Elzbieta Dworakowski; Hongfeng Jiang; Shonni J Silverberg; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2016-04-26       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.